{"id":1685,"date":"2024-11-09T05:43:17","date_gmt":"2024-11-09T05:43:17","guid":{"rendered":"https:\/\/neurologyconf.com\/?p=1685"},"modified":"2024-11-09T05:43:17","modified_gmt":"2024-11-09T05:43:17","slug":"fnirs-qeeg-pediatric-seizure-diagnosis","status":"publish","type":"post","link":"https:\/\/clsconf.com\/neurology\/fnirs-qeeg-pediatric-seizure-diagnosis\/","title":{"rendered":"Use of fNIRS and qEEG as a Novel Diagnostic Tool in Pediatric Seizure Disorders"},"content":{"rendered":"

Use of fNIRS and qEEG as a Novel Diagnostic Tool in Pediatric Seizure Disorders<\/h2>\n
\n

Seizure disorders in children are complex conditions, often challenging to diagnose with precision and requiring nuanced clinical approaches. At the 3rd European Congress of Neurology and Neuropsychiatry<\/strong><\/a>, taking place on February 17-18, 2025<\/strong>, in Amsterdam, Dr. Kamlesh Jha from the All India Institute of Medical Sciences (AIIMS), Patna, India<\/strong> will present an innovative keynote address on the use of functional Near-Infrared Spectroscopy (fNIRS)<\/strong> and Quantitative Electroencephalography (qEEG)<\/strong> as novel diagnostic tools in pediatric seizure disorders.<\/p>\n

Dr. Jha\u2019s pioneering work brings forth valuable insights into how these technologies can transform the diagnostic landscape, offering non-invasive and detailed neuroimaging insights that are particularly suitable for pediatric patients.<\/p>\n

More details: Neurology Conference Scientific Program<\/a><\/p>\n

About Dr. Kamlesh Jha<\/h3>\n

\"\"<\/p>\n

Dr. Kamlesh Jha is a professor of physiology<\/strong> and heads the Neurocognition and Sleep Unit<\/strong> within the Department of Physiology at AIIMS Patna. He also oversees the Advanced Centre for Evidence-Based Yoga Therapy and Research<\/strong> at his institute. With over 17 years of experience in medical teaching and research, Dr. Jha has contributed over 50 original research articles to prominent national and international journals. His extensive research background encompasses fields such as neurocognition, the therapeutic impact of yoga on neuropsychiatric conditions, qEEG, and fNIRS biomarkers, as well as the neurobiology of sleep. Besides his expertise in neurophysiology, Dr. Jha also harbors a scholarly interest in the Sanskrit language and literature, contributing to the cultural and intellectual enrichment of his students and colleagues.<\/p>\n

fNIRS and qEEG: Innovative Diagnostic Tools in Pediatric Seizure Disorders<\/h3>\n

Functional Near-Infrared Spectroscopy (fNIRS)<\/strong> and Quantitative Electroencephalography (qEEG)<\/strong> represent a new frontier in neuroimaging, particularly suited for the diagnosis and management of seizure disorders in children.<\/p>\n

    \n
  • fNIRS<\/strong>: Functional Near-Infrared Spectroscopy is a non-invasive imaging technology that measures cerebral blood flow and oxygenation levels, providing insights into brain activity in real time. In pediatric cases, fNIRS is valuable due to its child-friendly, non-invasive nature, allowing for accurate assessments of brain regions involved in seizure onset and propagation.<\/li>\n
  • qEEG<\/strong>: Quantitative Electroencephalography offers an objective analysis of brain electrical activity, generating precise data on brainwave patterns and identifying abnormalities linked to seizure activity. qEEG adds a quantitative layer to traditional EEG data, facilitating clearer diagnostic and treatment pathways for pediatric epilepsy and other seizure disorders.<\/li>\n<\/ul>\n

    Dr. Jha\u2019s keynote will explore the integration of these technologies in routine clinical settings, enabling improved accuracy in seizure localization, treatment monitoring, and prognostic assessment.<\/p>\n

    Diagnostic Utility in the European Market<\/h3>\n

    The European market for pediatric seizure disorder diagnostics is expanding significantly, with innovations like fNIRS and qEEG attracting considerable attention. The demand for precision diagnostics has grown, driven by increasing awareness and advocacy for pediatric neurology. According to recent market reports, Europe is witnessing a 5.7% growth rate in the adoption of neurodiagnostic tools, and investments in child-friendly, non-invasive diagnostic technologies are on the rise.<\/p>\n

    The utilization of fNIRS and qEEG aligns with Europe\u2019s goal to improve pediatric epilepsy outcomes. Countries like Germany, France, and the Netherlands are among the top adopters, recognizing the potential of these tools to reduce the burden of misdiagnosis and improve the quality of life for affected children and their families.<\/p>\n

    Why Attend the 3rd European Congress of Neurology and Neuropsychiatry?<\/h3>\n

    The Neurology Conference\u00a0<\/strong><\/a>will bring together global experts in neurology and psychiatry to discuss cutting-edge research and advancements under the theme \u201cBrain and Mental Health: Navigating the Future of Neurology and Psychiatry.\u201d<\/strong> Attendees can expect engaging presentations, insightful discussions, and networking opportunities with leading professionals in pediatric neurology and neurodiagnostics.<\/p>\n

      \n
    • Event Details<\/strong>:\n
        \n
      • Date<\/strong>: February 17-18, 2025<\/li>\n
      • Venue<\/strong>: Park Plaza Amsterdam Airport, Netherlands<\/li>\n
      • Theme<\/strong>: Brain and Mental Health: Navigating the Future of Neurology and Psychiatry<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n

        For registration inquiries, please contact info@neurologyconf.com<\/a><\/strong>. For general queries, reach out to secretary@neurologyconf.com<\/a><\/strong>.<\/p>\n

        Join us in Amsterdam to explore how advanced technologies like fNIRS and qEEG are redefining pediatric seizure diagnostics and to learn from leading experts such as Dr. Kamlesh Jha.<\/p>\n

        abstract<\/a><\/p><\/blockquote>\n